Development of a monoclonal anti-immunoglobulin E antibody (omalizumab) for the treatment of allergic respiratory disorders.
about
A review of omalizumab for the management of severe asthmaWhat Taiwan contributes to the world of allergy and clinical immunology?The role of omalizumab in the treatment of severe allergic asthma.Effects of omalizumab on basophil and mast cell responses using an intranasal cat allergen challenge.Reduced FcepsilonRI-mediated release of asthma-promoting cytokines and chemokines from human basophils during omalizumab therapy.Omalizumab modulates bronchial reticular basement membrane thickness and eosinophil infiltration in severe persistent allergic asthma patients.Asthma, airway biology, and nasal disorders in AJRCCM 2001.Omalizumab, an anti-immunoglobulin E antibody: state of the art.Linkage/association study of a locus modulating total serum IgE on chromosome 14q13-24 in families with asthma.Serum IgE Induced Airway Smooth Muscle Cell Remodeling Is Independent of Allergens and Is Prevented by OmalizumabEtiopathogenesis and management of perennial allergic rhinitis: a state-of-the-art review.A High Through-put Platform for Recombinant Antibodies to Folded Proteins.Evolution of anti-IgE treatment.Mechanisms in allergic airway inflammation - lessons from studies in the mouse.Pediatric Dosing and Body Size in Biotherapeutics.Use of biologicals as immunotherapy in asthma and related diseases.Inhibitory effects of anti-immunoglobulin E antibodies on airway remodeling in a murine model of chronic asthma.New and Emerging Targeted Systemic Therapies: A New Era for Atopic Dermatitis.The Role and Immunobiology of Eosinophils in the Respiratory System: a Comprehensive Review.IgE Depletion in Severe Asthma: What We Have and What Could Be Added in the Near Future.Successful treatment of bullous pemphigoid with omalizumab as corticosteroid-sparing agent: report of two cases and review of literature.Hyper-IgE Syndromes and the Lung.Omalizumab for treating chronic spontaneous urticaria: an expert review on efficacy and safety.Current and future applications of the anti-IgE antibody omalizumab.Development of eosinophilic granulomatosis with poliangiitis (Churg-Strauss syndrome) and brain tumor in a patient after more than 7 years of omalizumab use: A case report.Le rôle de l’omalizumab dans le traitement de l’asthme allergique grave.Effect of anti-IgE in occupational asthma caused by exposure to low molecular weight agents.Therapeutic Effect of Omalizumab in Severe Asthma: A Real-World Study in Korea.DW2008S and its major constituents from Justicia procumbens exert anti-asthmatic effect via multitargeting activity.
P2860
Q26741315-18FAA40D-53E2-488E-939A-C773852AB96CQ28661627-C19C35A2-B9E0-4562-B128-BEBB56386DF7Q33591890-FD5D04A8-98AD-45B5-9065-76FA26261D18Q33774675-C890C314-15A4-4F29-8DC6-2ABE4C4A74BDQ33785112-1D8383B3-4B7B-4877-ACEA-C19BA96AB451Q34303895-26CF56A7-8356-4C71-9E2C-FD87DCBBCBCFQ34550135-2A103C19-AAE6-4688-9267-B9618CB27DA5Q35095218-C3552A40-2C3F-4CCB-9AD1-993B33B9CD00Q35536221-0832DD99-8274-46A2-ABA2-0CF0AE592663Q35762396-B63D5195-F588-4DD8-B81C-21ECEF5101B1Q35790747-A2D96F5B-459E-4198-9871-46C8A44A297FQ36134059-04BF273F-2F01-4918-9711-1F3D3A461D89Q36870053-298B1888-F5AC-40A8-96D7-FC1EE5EB1F18Q37173306-C9454A86-13C6-411D-8490-A50111033590Q37666711-C18F0008-F8EF-4ED4-9888-D232A59A9386Q37754792-EED542A7-EAB9-445C-8FEC-247ED78DCC21Q38484785-E734792C-8E70-46A2-A715-180DA131FBFAQ38602326-463A9F69-CEEF-477E-95B0-CA64B0D4246EQ38707472-2D6A96CB-0A8D-438C-8E38-DD7ADA9A8B15Q38750724-D31D2253-CBE4-4DCA-930A-07CEC5CF0C98Q38881180-D6FBD8F1-DE68-4EE8-8131-059F3FCEF7F9Q38925032-EB491F1E-E4FE-4824-AFB1-928746542087Q38997626-438F971A-3A43-4436-B357-E57DB03A3207Q40119246-1F37567A-CCAB-43E5-9266-88B466AE8B67Q46257201-43ED6E13-D4C1-4D2E-9E86-46EC81D209D1Q47108024-D31B4AE7-C3C2-4A81-AED0-F9C1D4508B77Q47218290-7182775D-C9CB-498A-B338-66E70F8A2A00Q48091478-AA2F8C7D-0FE9-493E-91F9-DCADBCF114B9Q54993007-00C56009-2E7D-4333-858E-17CDCB0784AF
P2860
Development of a monoclonal anti-immunoglobulin E antibody (omalizumab) for the treatment of allergic respiratory disorders.
description
2001 nî lūn-bûn
@nan
2001 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Development of a monoclonal an ...... llergic respiratory disorders.
@ast
Development of a monoclonal an ...... llergic respiratory disorders.
@en
Development of a monoclonal anti-immunoglobulin E antibody
@nl
type
label
Development of a monoclonal an ...... llergic respiratory disorders.
@ast
Development of a monoclonal an ...... llergic respiratory disorders.
@en
Development of a monoclonal anti-immunoglobulin E antibody
@nl
prefLabel
Development of a monoclonal an ...... llergic respiratory disorders.
@ast
Development of a monoclonal an ...... llergic respiratory disorders.
@en
Development of a monoclonal anti-immunoglobulin E antibody
@nl
P2860
P1476
Development of a monoclonal an ...... llergic respiratory disorders.
@en
P2093
Schulman ES
P2860
P356
10.1164/AJRCCM.164.SUPPLEMENT_1.2103025
P407
P433
P577
2001-10-01T00:00:00Z